Gut-homing antibodies help protect against norovirus, paving path for new vaccines, therapies

Gut-homing antibodies help protect against norovirus, paving path for new vaccines, therapies

As the leading cause of viral gastroenteritis worldwide, norovirus is an all too familiar ailment. Its telltale digestive upset—not to mention its reputation for being notoriously contagious—has earned it the nicknames "winter vomiting bug" and "stomach flu." Yet despite millions of dollars spent on research, there are still no vaccines or anti-viral drugs for norovirus.

Gut punch: New study knocks out norovirus where it strikes

Gut-homing antibodies provide powerful protection against norovirus, a new Yale study finds, revealing a potential new path for developing vaccines and therapies.